Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. - Wikidata - wikimedia - TriplyDB

Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.

Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.

http://www.wikidata.org/entity/Q46220581

about

Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults Asthma: clinical expression and molecular mechanisms The use of inhaled corticosteroids in pediatric asthma: update Childhood asthma: diagnosis and treatment The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use Breaking new ground: challenging existing asthma guidelines Personal and ambient air pollution is associated with increased exhaled nitric oxide in children with asthma Monitoring asthma control using claims data and patient-reported outcomes measures The Saudi Initiative for Asthma.Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study Lessons learned from variation in response to therapy in clinical trials.Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma.In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma.Asthma and other recurrent wheezing disorders in children (chronic)Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program.Partner randomized controlled trial: study protocol and coaching intervention.Tiotropium bromide step-up therapy for adults with uncontrolled asthma The expert network and electronic portal for children with respiratory and allergic symptoms: rationale and design.Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma.Scientific respiratory symposium, paris june 2010 Biomarker-based asthma phenotypes of corticosteroid response.Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma Clinical and economic outcomes associated with low-dose fluticasone propionate versus montelukast in children with asthma aged 4 to 11 years.Lung function and biomarkers of airway inflammation during and after hospitalization for acute exacerbations of childhood asthma associated with viral respiratory symptoms Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network.Targeted interventions for difficult-to-treat asthma.Assessment of airway inflammation with exhaled NO measurement.Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.Exhaled nitric oxide in children with asthma and sinusitis.Immunoglobulin E blockade in the treatment of asthma.Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.Predictors of response to tiotropium versus salmeterol in asthmatic adults.

P2860

Q24197682-8F650EAE-71C4-48E9-BE75-610ADD4D731F Q24200804-2EDB0BA7-7752-460D-9B32-046BA4915F4A Q24202489-0DB6E456-72DE-42FC-8C8E-885A19636E01 Q24597331-06AE4911-258A-49C8-9BAA-EE8DCAD7ABF8 Q26739763-2E70C4CA-922B-4C2F-9487-6652D1241458 Q26863351-E5910168-BB11-4E06-A38D-C8407560E59C Q27025354-DF1C7457-BF10-4DC4-BD61-89FC301C19DE Q28211652-38C8D9F7-696B-4610-AAB9-A642101295A1 Q28766354-D5FB3EA3-2A24-4057-9CA7-C647345A2E8D Q33502728-8C76816E-0472-4E94-AF7A-0854867A2DE1 Q33568644-FF4D7B02-FF2D-4ACA-88C0-EF56AD19983C Q33755127-6D3DE707-4E0F-4EF5-AF34-1BDFEFE48481 Q33999050-EF53B4D7-4595-4F1E-BE84-488587C8E422 Q34112531-CD79D01E-0500-49BF-864B-01C992A22F24 Q34120964-56FEF802-1F58-430A-B8FE-B503E6CC23C4 Q34150855-CECE8A5C-C098-495A-A2CE-B9E305FF0DB5 Q34165210-889C1F55-49AD-4328-A1FD-93C2937B41F6 Q34216961-3AD9E15B-5F78-48C7-BB4C-8113BD65073C Q34444935-F7599484-2B80-42E0-B40F-91A2471AE426 Q34549851-4441A049-378B-469F-9923-E68815B6FC1D Q34625206-F8568480-463C-48A6-A124-FA1B35A8796E Q34923650-E9FE96F3-058E-4568-A341-1AFF47289F66 Q35117833-860F0FF9-C946-4E5B-8E52-D28F32515F5F Q35305384-5244434A-26BC-4363-8226-81F38D493ABD Q35598652-249752F2-46A5-480A-BEE6-72F39FD8397F Q35846993-D76874F9-B20D-429F-B2E6-5A762EE5E9CF Q36081869-133C09F7-F658-449F-A8CC-B95BE335F806 Q36198171-DFB1B11B-1AF4-47FD-AD22-8498D323BB87 Q36217677-435E017A-7CA2-4E0C-A43C-2AD84CCBE35D Q36422663-AABB1B0D-40FC-428E-82A2-F2666A9F1F45 Q36566081-E62FE6AE-88EE-4B33-90CC-FDEB7F6DB949 Q36671746-FFA2D664-9DBD-4664-B8BB-BDD1CE01B008 Q36675485-8D99F1DA-A3D6-466F-A32C-BCB906D5756F Q36765980-4A24261E-B9F0-4753-8B40-0763B4CA83ED Q36916936-6B169E44-C79F-488B-BF9C-8D6C10C8CEDE Q36927682-30E38F7C-34F0-4442-A953-76548B28E458 Q36951998-1344F9AA-CDDA-46AE-B9DA-B306A129E274 Q37142937-32D3B894-9C72-45F3-B721-6F28454643B4 Q37181742-7C51C7D5-CD26-4936-8076-F99C00F9BD7C Q37303840-17762B3B-35AC-42D7-8C51-C3ED00A1CEB9

P2860

Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.

http://www.wikidata.org/entity/Q46220581

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Response profiles to fluticaso ...... e persistent childhood asthma.

@en

Response profiles to fluticaso ...... e persistent childhood asthma.

@nl

type

label

Response profiles to fluticaso ...... e persistent childhood asthma.

@en

Response profiles to fluticaso ...... e persistent childhood asthma.

@nl

prefLabel

Response profiles to fluticaso ...... e persistent childhood asthma.

@en

Response profiles to fluticaso ...... e persistent childhood asthma.

@nl

P1433

Q46220581-3E073D58-3761-4283-8880-E98CD54D0E36

P1476

Q46220581-448FADB0-3CC1-402D-BC46-A4E0254D324B

P2093

Q46220581-00DEB24E-DAA2-45F6-A99E-9597063F6B9C

Q46220581-14EF2801-DB8D-4266-8813-06B4A241773D

Q46220581-24357688-AD24-463D-9F45-E76871CE4A75

Q46220581-59E1A0B8-AF57-4BC7-9270-0FC8B3667D6E

Q46220581-783633A3-64CA-42B7-A799-AA5DBF616DFB

Q46220581-7A6199CD-31CD-4C14-BE76-A90A6DCB2BFA

Q46220581-9BF02876-0A58-45C3-A2CD-7C8D4F30999E

Q46220581-A52EE23C-A0A8-4F3E-9BC4-DD6A1E58C28F

Q46220581-C1E12EA3-433B-4141-B783-CDBF2D95CFEC

Q46220581-D3E39A04-DE56-4714-B4B1-DB30F229E1B9

P304

Q46220581-9DC50C6F-390F-495D-AB24-AAFB1CFB2CDF

P31

Q46220581-B68BA789-CBD9-4122-852D-F1CE395497E4

P356

Q46220581-0739481A-4C5D-461C-ADF7-E632C58ABE57

P407

Q46220581-9BC6490C-A563-408D-9934-13065EA28044

P433

Q46220581-83983A8F-D44E-41E8-8A09-BC5193FAD90C

P478

Q46220581-04616128-00AF-4548-B305-6B96596E37F8

P50

Q46220581-1D239147-538D-49A2-9D80-04A57BD2F90B

Q46220581-2BB091F9-3FF1-4B27-852C-615462DB108D

Q46220581-67657132-ECAE-4198-8AF6-064A6055C5A2

Q46220581-85BAC7D2-2654-4E51-BB05-07F3E16D439E

Q46220581-A236CEDC-B0EB-473F-9E6E-02573DEAA806

P577

Q46220581-44647E48-A89D-47B3-A2CA-C57EA1C728E3

P5875

Q46220581-C054101E-34C0-48FE-B2FB-E5665EBFE6B1

P698

Q46220581-62D6746A-90AA-444D-BFC5-FC17E0A84C4E

P921

Q46220581-30307BD7-03F4-4501-8EF9-506C768FB912

P356

J.JACI.2005.10.012

P1433

The Journal of Allergy and Clinical Immunology

P1476

Response profiles to fluticaso ...... e persistent childhood asthma.

@en

P2093

Brenda R Phillips

http://www.w3.org/2001/XMLSchema#string

Childhood Asthma Research and ...... art, Lung, and Blood Institute

http://www.w3.org/2001/XMLSchema#string

Christine A Sorkness

http://www.w3.org/2001/XMLSchema#string

Fernando D Martinez

http://www.w3.org/2001/XMLSchema#string

Gary Larsen

http://www.w3.org/2001/XMLSchema#string

Gordon R Bloomberg

http://www.w3.org/2001/XMLSchema#string

Gregory Heldt

http://www.w3.org/2001/XMLSchema#string

Joseph D Spahn

http://www.w3.org/2001/XMLSchema#string

Lynn M Taussig

http://www.w3.org/2001/XMLSchema#string

Mark H Moss

http://www.w3.org/2001/XMLSchema#string

P304

45-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2005.10.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Theresa W. Guilbert

Robert S. Zeiger

Stanley J Szefler

Robert F Lemanske

Leonard B Bacharier

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7382962

http://www.w3.org/2001/XMLSchema#string

P698

16387583

http://www.w3.org/2001/XMLSchema#string

P921